Indexed keywords
ANTIHYPERTENSIVE AGENT;
VASODILATOR AGENT;
AGED;
ARTICLE;
BLOOD PRESSURE;
COHORT ANALYSIS;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
GERIATRIC ASSESSMENT;
HEALTH STATUS;
HEART OUTPUT;
HUMAN;
IDIOPATHIC PULMONARY HYPERTENSION;
MALE;
METHODOLOGY;
PULMONARY HYPERTENSION;
RETROSPECTIVE STUDY;
STATISTICS;
SURVIVAL;
TREATMENT OUTCOME;
UNITED STATES;
VASCULAR RESISTANCE;
AGED;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CARDIAC OUTPUT;
COHORT STUDIES;
CONNECTICUT;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GERIATRIC ASSESSMENT;
HEALTH STATUS;
HUMANS;
HYPERTENSION, PULMONARY;
MALE;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VASCULAR RESISTANCE;
VASODILATOR AGENTS;
1
79751478640
wwwamericangeriatrics.org
2
0023615359
Primary pulmonary hypertension. A national prospective study
Rich S, Dantzker D,Ayres S, et al: Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216-23. (Pubitemid 17137857)
(1987)
Annals of Internal Medicine
, vol.107
, Issue.2
, pp. 216-223
Rich, S.1
Dantzker, D.R.2
Ayres, S.M.3
3
17844389580
Primary pulmonary hypertension in Israel: A national survey
DOI 10.1378/chest.119.6.1801
Apppelbaum L,Yigla M, Bendayan D, et al: Primary pulmonary hypertension in Israel: A national survey. Chest200l; 119: 1801-6. (Pubitemid 32744938)
(2001)
Chest
, vol.119
, Issue.6
, pp. 1801-1806
Appelbaum, L.1
Yigla, M.2
Bendayan, D.3
Reichart, N.4
Fink, G.5
Priel, I.6
Schwartz, Y.7
Richman, P.8
Picard, E.9
Goldman, S.10
Kramer, M.R.11
4
33646269035
Pulmonary arterial hypertension in France: Results from a national registry
Humbert M, Sitbon 0, Chaouat A, et al: Pulmonary arterial hypertension in France: Results from a national registry Am JRespir Crit Care Med 2006; 173:1023-30.
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 1023-30
Humbert, M.1
Sitbon, O.2
Chaouat, A.3
5
33846330126
Unexplained pulmonary hypertension in elderly patients
DOI 10.1378/chest.06-1571
Shapiro B,McGoon M, Redfield M: Unexplained pulmonary hypertension in elderly patients. Chest 2007; 131:94-100. (Pubitemid 46122979)
(2007)
Chest
, vol.131
, Issue.1
, pp. 94-100
Shapiro, B.P.1
McGoon, M.D.2
Redfield, M.M.3
6
3142692425
Screening early detection and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
McGoon M, Gutterman D, Steen V, et al: Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest2004; 126:lls-13s.
(2004)
Chest
, vol.126
McGoon, M.1
Gutterman, D.2
Steen, V.3
7
0025837793
Survival in patients with primary pulmonary hypertension: Results from a national prospective registry
D'Alonzo G, Barst R,Ayres S, et al: Survival in patients with primary pulmonary hypertension: Results from a national prospective registry. Ann Intern Med 1991; 115:343-9.
(1991)
Ann Intern Med
, vol.115
, pp. 343-9
D'Alonzo, G.1
Barst, R.2
Ayres, S.3
8
0037126044
Survival in primary pulmonaryhypertension:The impact ofepoprostenol therapy
McLaughlin V, Shillington A, Rich S: Survival in primary pulmonaryhypertension:The impact ofepoprostenol therapy. Circulation 2002; 106:1477-82.
(2002)
Circulation
, vol.106
, pp. 1477-82
McLaughlin, V.1
Shillington, A.2
Rich, S.3
9
13844280943
Survival with first-line bosentan in patients with primary pulmonary hypertension
DOI 10.1183/09031936.05.00054804
McLaughlin V, Sitbon 0, Badesch D, et al: Survival with first-line bosentan in patients with primary pulmonary hypertension. EurRespirJ200S; 25:244-9. (Pubitemid 40246523)
(2005)
European Respiratory Journal
, vol.25
, Issue.2
, pp. 244-249
McLaughlin, V.V.1
Sitbon, O.2
Badesch, D.B.3
Barst, R.J.4
Black, C.5
Galie, N.6
Rainisio, M.7
Simonneau, G.8
Rubin, L.J.9